Cited by 21Burkholderia infections and melioidosisInfections and bacterial resistanceAntibiotic Resistance in Bacteria

A case of pan‐resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy

Open access
Cantón‐Bulnes, María Luisa, Hurtado Martínez, Ángela, López‐Cerero, Lorena, Arenzana Seisdedos, Ángel, Merino‐Bohorquez, Vicente, Garnacho‐Montero, José·2019·Transplant Infectious Disease

Abstract

We describe a case of one patient with cystic fibrosis who developed a pan‐resistant Burkholderia cepacia complex rapidly progressive bacteraemic pneunonia, following bilateral lung transplantation. The patient was treated with a targeted combination antibiotic therapy (meropenem plus ceftazidime/avibactam plus high doses of nebulized colistimethate sodium). Evolution of the disease was complicated by multiple organ system dysfunction. Finally, clinical improvement and microbiological cure was achieved.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/tid.13034

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with B. cepacia complex may be candidates at specialized centers that have attained satisfactory outcomes with protocols implementing newer antibiotic combinations and intense management of sinusitis.

    “patients may be candidates at specialized centers that have attained satisfactory outcomes with protocols implementing newer antibiotic combinations and intense management of sinusitis.(74–77)”

    From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [76]

    The Discussion reports that BCC infection is not an absolute contraindication to lung transplantation, that individual centers can determine their practice, and that one patient was cured with a targeted antibiotic combination. It does not report satisfactory outcomes from specialized-center protocols or intensive management of sinusitis; the case history mentions chronic rhinosinusitis but not its intensive treatment. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Safe lung transplantation is possible in patients with hepatitis B virus if appropriate antiviral agents are used after transplantation.

    “Safe lung transplantation is also possible in patients with hepatitis B virus, similarly to the transplantation of other solid organs, if appropriate antiviral agents are used after transplantation [30].”

    From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [30]

    The case report describes lung transplantation in a patient with cystic fibrosis and subsequent treatment of Burkholderia cepacia complex pneumonia (Abstract and Discussion; page numbers unavailable). Its mention of post-transplant antiviral prophylaxis does not address hepatitis B. Searches for hepatitis B, HBV, and antiviral treatment in transplant recipients found no passage supporting the claim. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cantón‐Bulnes, M. L., Hurtado Martínez, Á., López‐Cerero, L., Arenzana Seisdedos, Á., Merino‐Bohorquez, V., & Garnacho‐Montero, J.
Affiliations
  • Hospital Universitario Virgen Macarena (ES)
  • Unidad de Cuidados Intensivos, Hospital Universitario Virgen Macarena Sevilla Spain
  • Servicio de Farmacia Hospital Universitario Virgen Macarena Sevilla Spain
Corresponding author
Cantón‐Bulnes, María Luisa
Venue
Transplant Infectious Disease
Publisher
Wiley
Published
2019-01
Volume
21
Issue
2
Pages
e13034-e13034
ISSN
  • 1398-2273 (ISSN-L)
  • 1399-3062
OpenAlex
W2904599441
Cited by
21
References
14
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 2
FWCI
2.15
Type
journal article
Language
en
Open access
Locations
  • Transplant Infectious Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Epidemiology › Burkholderia infections and melioidosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Infections and bacterial resistance
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
Keywords
Burkholderia cepacia complex, pan-resistant bacteria, lung transplantation, cystic fibrosis, meropenem, ceftazidime-avibactam, combination antibiotic therapy, multiple organ failure
MeSH terms
Adult, Anti-Bacterial Agents, Colistin, Cystic Fibrosis, Humans, Male, X-Rays, Lung Transplantation, Bacteremia, Treatment Outcome, Pneumonia, Bacterial, Burkholderia Infections, Drug Resistance, Multiple, Bacterial, Burkholderia cepacia complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review